Unblocking Barriers of Access to Hepatitis C Treatment in China: Lessons Learned from Tianjin

• Main Authors: Peiwen Zhang (Author), Ran Guo (Author), Jun Lian (Author), Mengjia Zhi (Author), Chengzhen Lu (Author), Weishen Wu (Author), Lihong Wang (Author), Polin Chan (Author), Zhongdan Chen (Author), Jing Sun (Author)
• Format: Book
• Published: Ubiquity Press, 2020-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The high price is a critical barrier of access to new direct-anting-antiviral (DAA) therapies for hepatitis C for both the patients and the society. Many countries continue to face the challenge of financing such expensive medicines. Such examples include both high-income and middle-inco...